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Abstract
Background: The cause of severe disease in some patients infected with pandemic influenza A virus is unclear.
Methodology/Principal Findings: We present the cellular immunology profile in the blood, and detailed clinical (and post-
mortem) findings of three patients with rapidly progressive infection, including a pregnant patient who died. The striking
finding is of reduction in natural killer (NK) cells but preservation of activated effector CD8 T lymphocytes; with viraemia in
the patient who had no NK cells. Comparison with control groups suggests that the reduction of NK cells is unique to these
severely ill patients.
Conclusion/Significance: Our report shows markedly reduced NK cells in the three patients that we sampled and raises the
hypothesis that NK may have a more significant role than T lymphocytes in controlling viral burden when the host is
confronted with a new influenza A virus subtype.
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Introduction
The recent H1N1/09 swine-origin influenza pandemic appears
to have a high infectivity rate but low pathogenicity [1]. However,
it is clear that some subgroups of patients have a poorer outcome –
the Mexico outbreak suggested that younger patients, especially
those with co-morbidities and morbidly increased BMI were more
susceptible to respiratory failure [2]. More recently, surveillance
study from 2005 to April 2009 in that area confirms that
peaks for mortality and morbidity in the new H1N1/09 strain,
have shifted from the very old and young (below 5 and above
80 years of age) to those between the ages of 5 and 59 years, with a
focused peak in both deaths and pneumonia in the 20 to 44 age
group [3]. The cause of severe illness in this compared to the older
age groups is unclear. There is some evidence to suggest lack of
cross-reactive immunity from previous subtypes of influenza A
viruses, though neither this nor the actual mechanism of immune
protection is clear. Studies in mice suggest that T lymphocytes
and the innate immune arm (monocytes, macrophage and
neutrophils) are involved in both immune-protection and
pathology [4] but the factors involved in protection in some
patients and tissue injury in others and the relative contribution
of various immune cell subsets to these outcomes have not been
established in mice or humans. The current pandemic and
samples stored from patients offers an opportunity to clarify some
of these questions and ultimately improve management of severely
ill patients with influenza virus infection. To provide one starting
platform, we report here the salient clinical features and
immunological profile from three cases of severe illness from
patients in this peak mortality age group, sourced from the first
outbreak in UK, including histology of lung sections from post
mortem study of one fatal case.
Methods
Case patients
The cases reported here (Patient 1–3) represent the first wave of
patients admitted to Intensive Therapy Unit (ITU) in the first UK
outbreak of H1N1/09. Clinical data were presented in detail and
captured from case notes.
Blood sample for isolation of peripheral blood mononuclear
cells (PBMCs) was obtained during the period of acute illness
period in Patient 1, and after clinical recovery in Patient 2 and 3
(see clinical course for timings).
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As a comparison and control for these flow cytometric findings,
PBMCs from seven healthy, uninfected individuals [mean 32.6
(S.D. 8.9) years old]; three healthy, uninfected pregnant women
(35, 31 and 34 years old; 37,26 and 35 weeks pregnant
respectively) and four patients who had confirmed H1N1/09
infection but did not require mechanical ventilatory support
(‘H1N1/09, non-ITU’). Of the four, one was 29 years old with no
previous illness and not hospitalised; the other three were 55, 26
and 47 years of age, and hospitalised for 4–10 days. They
presented with mild dyspnea, fever and cough; and recovered
quickly without requiring ITU or mechanical ventilatory support.
One patient also had asthma, the others had no concomitant
clinical conditions. All samples were collected within three days of
hospital admission (the non-hospitalised subject was also sampled
within three days of symptom onset). Three patients admitted to
Intensive Therapy Unit and ventilated for other conditions [post-
abdominal surgery (anterior resection), pneumonia, and post-
esophagectomy] provided a comparison for severe illness requiring
ITU support (labelled as ‘non-flu, ITU’). These samples were also
analysed using similar conditions; and cells were extracted and
stored using the same methods. All individuals in comparison
groups were clinically assessed by a senior respiratory physician.
Cellular immunology profile in peripheral blood
PBMCs were obtained using Ficoll separation and stored in
DMSO/FCS at 280uC according to previously described
methods [5].
To determine the T lymphocyte profile, we examined the
proportion of activated effector CD8 T cells (as described by
Miller JD et al [6]) using a combination of CD38, CD8 and HLA
DR mAb staining by flow cytometry. Influenza virus-specific CD8
T lymphocytes in the peripheral blood were determined using
MHC-1 tetrameric complex (HLA*A0201) loaded with peptide
(GILGFVFTL) derived from the conserved M (Matrix M58-66)
virus protein, using methods first established in our laboratory
[7,8]. Two of the three infected, ventilated patients, one of the
three infected, non-ventilated, and three healthy subjects were
HLA*A0201, permitting the use of this reagent on their blood. We
also examined the CD4:CD8 T lymphocyte ratio, the proportion
of inflammatory monocyte (CD14
+ and CD16
+) [9] and
neutrophil (FSC/SSC configuration and CD11b), invariant
natural killer T cells (CD3
+,V b11
+ and 6B11
+) [10], and natural
killer cells (CD3
2 and CD56
dim and CD56
bright) [11]. Dead cells
were gated out with Hoechst staining [12]. All antibodies were
obtained from eBiosciences (Hatfield, UK). Methods for flow
cytometry staining are as previously described [5,13].
In order to examine if the freeze and thaw procedure
disproportionately affected viability of the cells, we compared
staining of fresh and stored samples from all of the healthy,
uninfected individuals using the same panel of mAbs; and also
from five patients with acute seasonal influenza virus infection to
examine storage effects on activated immune cells which may be
more sensitive to cell death.
Examination of post mortem lung sample
Post mortem lung sample from Patient 1 was stored in
paraformaldehyde and embedded in paraffin for haematoxylin
and eosin staining. Identity of the cell infiltrates was determined
with a combination of haematoxylin staining and immunohisto-
chemistry staining for CD68 (macrophages), CD3 (T cells), CD56
(NK cells) and CD20 (B cell) after antigen retrieval using
microwave and citrate or EDTA buffer methods [14]. All were
detected using a two-step peroxidase staining kit (Dako UK)
according to manufactory instruction and as described previously
[14]. Appropriate controls (including uninfected normal lungs
sections) were used for all staining.
Diagnosis and detection of virus in samples
Serial respiratory and EDTA plasma samples were obtained
from all patients admitted to the ICU and first tested using a
validated in-house generic influenza A real time assay based on the
Matrix gene, and confirmed with swine-origin H1N1/09 specific
Matrix gene as recently described [15]. The crossing threshold (Ct)
value (at the inflexion spot of the sigmoid amplification curve to
capture the point where DNA amplification is exponential) was
recorded for all positive results. This represents positive pick-up of
RNA against blank (no RNA). Ct for the ‘no RNA’ control was
greater than 40. In Patient 1, post mortem lung, lymph nodes,
spleen, liver, distal small bowel and kidneys were also examined
for presence of swine-origin H1N1/09 viral RNA. These results
were compared with 52 paired blood and nasopharyngeal swabs
obtained from community cases of H1N1/09 infection during the
first phase of the Scottish outbreak in July-August 2009.
Ethics
Patients 2 and 3, and the next of kin of Patient 1 gave informed
written consent for the studies performed on their samples and
publication of their cases. Participation of the control cases was
approved by the Oxfordshire Research Ethics Committee.
Results
Relevant patient clinical details
All patients had swine-origin H1N1/09 influenza, detected as
described above, and received Oseltamivir. Details of longitudinal
changes in organ function, haematological indices and inflamma-
tory markers are shown in Figure 1. Admission drugs, radiologist
reports of presenting chest radiograph (CXR) and absolute blood
leukocyte counts at the point of sampling for PBMCs are displayed
in Table 1. All reference to ‘Days’ in text and figures denote days
after onset of symptoms. None of the patients were knowingly in
contact with infected or exposed individuals or travelled abroad in
the few months prior to admissions.
Clinical course
Patient 1. 38 yr old woman, smoker (25–40 cigarettes/day),
29 weeks pregnant; previous history of left parietal lobe infarction
in 1999 secondary to high-grade stenosis of left carotid artery,
resulting in residual right-sided hemiplegia and minor expressive
dysphasia. Presented with three to four days history of
progressively worsening dyspnoea, pyrexia and cough. She was
admitted on Day 4 and started on broad-spectrum antibiotics. A
CT pulmonary angiogram on Day 5 excluded pulmonary
embolism but showed extensive bilateral lower lobe pneumonic
consolidation (Figure 2a). She was intubated on day 6 after rapidly
progressive respiratory failure. Neonate was delivered on Day 7.
Progressive deterioration in liver function was recorded from Day
8, and renal impairment from day 10. Blood sample for PBMC
was collected on Day 18. Patient died 2 days later from multi-
organ (lungs, liver, heart) failure. CXR series showed progressive,
widespread consolidation throughout disease course. Post mortem
was performed 48 hours later, and lung samples collected. Viral
RNA was detected in blood on day 7, 11 and 13 after admission,
and in post mortem lungs, blood and lymph nodes but not in any
other organs (Table 2). Repeated blood cultures, tracheal aspirates
and line tip cultures showed no bacterial growth.
NK Cells Severe Influenza
PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10675Figure1.Longitudinalchangesinorganfunctionfromonsetofsymptoms(Day1).Biochemical and haematological indices werecaptured every
two days throughout disease course for Patient 1 (column A), Patient 2 (column B) and Patient 3 (column C). Relevant clinical and therapeutic interventions
areshownontheureaandcreatinineserialgraphforeachpatient.NormallevelsareUrea–2.5–7.5 mmol/l;Creatinine-40–139 umol/l;Hb-12.0–17.5 g/dl;
lymphocytes – 1.5–3.5610‘9/l; monocytes 0.2–0.8610‘9/l; neutrophils 2.5–7.5610‘9/l; ALT- 0–50U/l; albumin - 32–45 g/l; CRP - 0–10 mg/l.
doi:10.1371/journal.pone.0010675.g001
Table 1. Admission drugs, Radiologist Reports of Presenting chest radiograph (CXR) and absolute blood leukocyte counts at the
point of sampling of PBMC used for phenotyping.
Patients
12 3
Age 38 38 24
Gender F M F
Presenting CXR Ill defined patchy consolidation
in right and left lower zones
Patchy bilateral upper, mid and lower
zones consolidations
Extensive right lower lobe consolidation
and left lower zone patchy consolidations
Lymphocytes (x10‘9/l)
(normal: 1–4)
3.9 2.6 2.6
Neutrophil count (x10‘9/l)
(normal: 2.5–7.5)
19.9 7.4 3.0
Monocytes count (x10‘9/l)
(normal 0.2–0.8)
0.3 0.9 0.4
Drugs on admission to hospital Aspirin 75 mg Folic acid 5 mg
Ferrous sulphate 600 mg
Orlistat 360 mg Simvastatin 40 mg Aspirin
75 mg Omeprazole 20 mg Lisinopril 20 mg
Frusemide 40 mg Carvedilol 12.5 mg
Nitrazepam 5 mg
None
doi:10.1371/journal.pone.0010675.t001
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diabetes mellitus, alcohol-related dilated cardiomyopathy (ejection
fraction of 60–65% on admission; diagnosed 2001). Body mass index
29.5, HbA1c in April 2009 was 7.2%; plasma glucose usually poorly
controlled. Presented with dyspnoea and admitted directly to ICU on
arrival to hospital. CXR on admission showed patchy areas of
consolidation bilaterally (Figure 2b) and increased opacification
laterally which may be caused by collection of pleural fluid or dense
consolidation(thoracicultra-soundscanwasnotperformed).Therewas
progressive and extensive nodular airspace opacification but some
improvementwasreportedfromDay13,thoughthesechangespersisted
until Day 22. Broad-spectrum antibiotics were commenced on Day 2.
Diseasecoursewascomplicatedbyrenalandliverfunctionimpairment;
neitherwasabnormalbeforeadmission(Figure1b).Hewaswellenough
to be extubated and discharged to the ward on Day 22 and went home
on Day 27. Blood sample for PBMC was obtained on Day 46. Sputum
sample on Day 2 showed heavy growth of Haemophilusinfluenzae. No
other relevant growth in other cultures throughout admission.
Figure 2. Radiographic images at presentation for Patient 1–3. Cut (mediastinal window) from mid thoracic region of the CT pulmonary
angiogram of Patient 1 showing bilateral widespread nodular consolidation (A). The CTPA was reported as showing extensive inflammatory change in
both lungs with solid consolidation of both lower lobes and right middle lobe; with widespread patchy infiltration in both upper lobes. CXR for
Patient 2 (B) on day of intubation showed bilateral mid and lower zone consolidations, and possible left pleural fluid collection; and for Patient 3 (C)–
extensive right lower lobe consolidation and patchy consolidation in left lower lobe; enlarged cardiothoracic ratio and evidence of pulmonary edema.
doi:10.1371/journal.pone.0010675.g002
Table 2. Viral RNA in Samples from Patients 1–3.
Respiratory samples
(Ct)
Blood samples
(Ct)
Post Mortem (Patient 1 only)
(Ct)
Days in ITU Naso-pharyngeal swab Endotracheal aspirate Plasma Lung Lymph node Spleen Liver Kidney
Patient 1 1 27.5
3
6 24.9
7 27 24.9 34.6
11 25.9 31.9
13 31.2
PM 34.1 36.3 neg neg neg
Patient 2 1 36.3
3 25.9
52 9
10 35.7
12 Neg
17 Neg
Patient 3 1 38.4
3 Neg Neg
5N e g
7 35.2
10 37.6
Note. – Neg = Negative
doi:10.1371/journal.pone.0010675.t002
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previous hospital admission or regular treatment for asthma), and
atrial septal defect repaired in 2007; life-long non-smoker. Admitted
to hospital with three days of vomiting, diarrhoea, malaise, fever,
headache and dyspnoea. She had productive cough on admission
(Day 3) with extensive right lower lobe and patchy left basal
consolidation on CXR (Figure 2c). Broad-spectrum antibiotics were
started on Day 3. She was transferred to ICU and intubated on Day
6 and remained in ICU for 11 days, with only one organ failure
(lungs). Blood sample for PBMC was obtained on Day 34.
Effect of freeze and thaw on immune cells of healthy and
infected samples
We found both CD14
+ and CD16
+ monocytes significantly
reduced after storage (the latter, thought to represent inflamma-
tory monocytes [9] in humans were more markedly affected).
Invariant NKT cells, possibly owing to the rare nature of the cells,
showed variable degrees of loss but all other cells remained stable
after storage (data not shown). We have therefore not reported on
monocytes or invariant NKT cell frequencies.
Immunological profile in peripheral blood
There was an increased proportion of activated effector CD8 T
cells in the circulating blood as expected [6,16] [mean of
2.062.2% (S.D.) of live PBMCs compared to 0.2560.16% in
healthy uninfected; p=0.04, Student’s t test], but no expansion of
influenza virus specific T cells to Matrix peptide in the peripheral
blood, and no significant difference in the CD4:CD8 ratio
compared to healthy uninfected population (mean of 2.460.5 vs
1.860.2; p= 0.06, Student’s t test) (Figure 3a,b,d); though the
trend was for higher CD4:CD8 ratio in the cases. One healthy
volunteer had detectable Matrix peptide-specific T cells (H5); and
the one of four H1N1/09 infected, non-ventilated patient who was
HLA*A0201 also showed a virus-specific T cell response
(P4)(Figure 3d).
Both infected, non-ventilated (n=4), and the non-infected,
ventilated (n=3) patients showed a markedly raised CD4:CD8
ratio suggesting that increased peripheral CD4:CD8 T cell ratio is
a feature of acute illness. This concurs with the fact that 2 of the
three infected, ventilated patients (our primary cases) had blood
sampled after the acute infection and discharge, while all the other
7 patients were sampled during the acute period of illness, while
they were still hospitalised.
Unexpectedly, NK cells were markedly reduced in all three
severely ill, ventilated H1N1/09 infected patients (Figure 3c)
(mean of 2.461.8% of live cells vs 10.962.4 in healthy uninfected,
p=0.001; Student’s t test); none was found in Patient 1 who was
pregnant. Both CD56
bright and CD56
dim subsets of NK cells were
Figure 3. T lymphocyte and NK cell profile in blood of patients. (A -C) Activated effector CD8 T cells, CD4:CD8 T lymphocyte ratio and NK cell
frequencies in the three patients (H1N1/09 ITU) compared to the other groups as described in Methods. (D) CD8 T lymphocytes specific to H1N1
matrix epitope as detected by MHC1 tetramer loaded with Matrix peptide. P1 – Patient 1; P2 – Patient 2; C1 – non-HLA A*0201 individual as control
(should not stain); H2 and H5 – two healthy individuals with HLA A*0201 genotype; P4 – infected, non-ventilated patient with HLA A*0201 genotype.
H5 had symptoms suggestive of influenza virus A infection a few years ago. (E). NK cells identified by CD56
+ and CD3
- staining. NK cells were all
CD16
+ for P2 and 3. P1-3 – Patient 1-3; Pr1-3 – healthy uninfected pregnant women; H1-6 – healthy uninfected individuals. In (D), % refers to
frequencies of tetramer
+ cells as proportion of CD3 T cells. And in (E), both CD56
bright and CD56
dim subsets as proportion of live PBMCs.
doi:10.1371/journal.pone.0010675.g003
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CD56
hi, which was expected [11] (Figure 3e).
Analysing the NK and CD8 effector T cells in absolute values (ie
number of cells/l of blood) rather than proportions, we also found
reduced NK cells and elevated CD8 effector T cells – mean
(6S.D.) of 72 (30) 610
‘6/l vs 153(614) 610
‘6/l for NK cells in
cases compared to healthy controls; and 61(637) 610
‘6/l vs
3.6(60.9) 610
‘6/l for CD8 effector T cells in cases compared to
healthy controls.
Post mortem lung findings for Patient 1
The most striking finding from the haematoxylin and eosin
sections is diffuse alveolar damage (DAD) with characteristic
pulmonary oedema and fibrin deposition in the alveolar space
(Figure 4a). Large areas of haemorrhage were evident throughout
a severely injured lung characteristic of fulminant acute respiratory
distress syndrome. There were no areas of normal lung
parenchyma; inflammatory infiltrates were scarce. Where present,
these were predominantly CD3
+ T cells, with scattered CD20
+ (B)
cells and no CD56
+ (NK) cells (Figure 3b-d). Macrophages were
evident both morphologically and confirmed with CD68
+ staining
(Figure 3e). No infiltrates of polymorphs were observed.
Viral RNA in patient samples
Viral RNA was detected in nasopharygeal swab and endotra-
cheal aspirate of all patients but only in plasma of Patient 1
(Table 2). None was detected in any of the 52 community blood
samples which tested positive for swine-origin H1N1/09 viral
RNA on nasopharyngeal swabs. The virus RNA levels remained
high in endotracheal secretions for patient 1 throughout the
disease course in contrast to Patients 1 and 2; and her plasma viral
RNA levels increased with worsening illness.
Discussion
In this report, we provide a detailed clinical course on three
severely ill patients infected with H1N1/09. In the first patient,
the progression of disease was quick and her only risk factor was
pregnancy. In spite of Betamethasone (administered to enhance
maturation of the foetal lungs), 200 mg Hydrocortisone, 20 g
human immunoglobulin infusions, high dose Oseltamivir
(150 mg bd), Ribavarin and broad-spectrum antibiotics, she
succumbed to progressively worsening lung injury and likely
disseminated viral infection. She had peripheral lymphopaenia in
the early part of her illness (Figure 1a) but there were no
abnormalities in the composition of her circulating PBMCs. Most
strikingly, H1N1/09 viral RNA was detected not only in the
respiratory tract but also in her blood by day 7 of her ICU stay
(Day 13 post onset of symptoms on graph, Figure 1a). Increasing
level of viral RNA in the blood corresponded with worsening
neutrophilia and deterioration in liver function. This could be
due to bacterial superinfection at this point and may be
contributing factor to the patient’s death. For Patient 2, his viral
disease was complicated by H influenza pneumonia but despite
this, several risk factors, and multi-organ impairment (cardio-
respiratory, renal and liver); he made a good recovery. Other
than the factor of pregnancy and lack of detection of viral RNA
in blood, one major difference was the administration of
hydrocortisone early in the course of disease. Patient 1 was
administered 12 mg Betamethasone intramuscularly early (on two
consecutive days); this dose was equivalent to approximately 64
mg of hydrocortisone (Patient 2 received 200 mg/day for 8 days)
(Figure 1a&b). Patient 3 had relatively mild disease compared to
Patient 1 and 2 but progressed rapidly to respiratory failure. She
had single organ failure and made an uncomplicated recovery.
Corticosteroids were not administered.
Like the reports from Mexico [3], all three patients presented
with rapidly progressive and widespread pneumonic consolidation
on chest X ray. Although it was suggested that the patients in the
Mexican outbreak had primary viral pneumonia, it is not possible
to confirm this in our three patients as they all received broad-
spectrum antibiotics early. However, it is highly likely that this is
the case with Patient 1 as there was no evidence of neutrophilic
infiltrate in the lung sections.
In the post mortem lungs of Patient 1, the major histopatho-
logical finding was diffuse alveolar damage (DAD), reflecting the
clinical syndrome of acute respiratory distress syndrome (ARDS).
There was complete obliteration of airspace with oedema and
haemorrhage but scanty cellular infiltrate – any was composed of
T cell and macrophages. Macrophage infiltrate was distinct and
calls into question its role in tissue injury. These post mortem
changes are very similar to those described for cases from the 1918
pandemic and epidemics since then [17], in the autopsy series on
fatal cases of severe acute respiratory syndrome (SARS) [18], and
reported fatal H5N1 cases [19].
The blood samples for immunological profile were obtained at
different phases of disease [acute in Patient 1 vs recovered (at least
10 days after resolution of symptoms) in Patients 2 and 3]; but in
all patients, the NK cells were reduced, in contrast to the effector
CD8 T cells which showed no abnormality. In Patient 1, there was
a complete loss of NK cells in the peripheral blood. She was also
the only patient in whom viral RNA was detected in the blood,
raising the suggestion of relative greater importance of NK cells to
T cells in controlling virus load and spread, particularly for a virus
not previously encountered by the host. None of the 52
community patients with milder symptoms had detectable viral
RNA, providing some support for correlation between Ct levels,
viral burden and disease severity.
NK cells are a key component of the innate immunity. They
represent about 5–20% of circulating peripheral blood lympho-
cytes and rapidly accumulate in organs during viral infections,
tumour growth and inflammation. The role of NK cells in
influenza A virus infection is understudied but animal studies have
shown that NK cell depletion or mice lacking the full repertoire of
the NK cells recognition receptors (NCR-1 deficient mice)
exhibited increased morbidity and mortality following influenza
A virus infection [20–21]. Receptors on NK cells (NKp46) can
recognize the viral haemaglutinin, and NK cells can respond to
influenza A virus infection by augmenting their cytolytic function
[22–23], suggesting involvement of these cells during influenza
virus infection.
NK cells have both cytotoxic and cytokine-producing functions
which are controlled by a complex panel of activating and
inhibitory receptors [11]. A set of inhibitory receptors, called killer
cell immunoglobulin-like receptors or KIRs have a central role in
the regulation of NK cell function. The KIR gene cluster and its
ligand HLA class I loci is diverse and there is evidence to suggest
that NK cell immune responses are genetically determined to
some extent [24]. Certain KIR/HLA compound genotypes
resulting in the presence of greater NK activating profile are
associated with resistance to Hepatitis C virus and HIV infection,
slower HIV disease progression and reproduction success [25–28].
In a recent paper, Ahlenstiel G and colleagues showed that these
compound genotypic differences resulted in different type I
interferon response of NK cells infected with influenza A virus
[29]. Thus although it is unclear if the reduction of NK cells in our
patients is a primary event increasing the susceptibility of disease
or a secondary effect of viral infection, Ahlenstiel’s study suggests
NK Cells Severe Influenza
PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10675Figure 4. Histopathology sections from lungs of Patient 1. (A) H&E section showing fulminant diffuse alveolar damage (DAD), arrows indicate
pulmonary oedema (i) and hyaline membrane formation (ii). (B) High magnification of an area of inflammatory infiltrate showing predominantly
lymphocytes (iii) and macrophages (iv). (C)-(H) – Immunohistochemistry staining of lungs showing: (C) occasional CD20 (B cell) staining (v); (D) control
showing B cells in a lung section from a patient with rheumatoid nodule (positive cells in dark brown); (E) CD56 (NK cell) staining in Patient 1 showed
NK Cells Severe Influenza
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can infect NK cells directly [30] and the reduction of NK cells may
be a consequence of this or activation-induced cell death.
The loss of NK cells was most striking in Patient 1 who was
pregnant. Very little is known as to why pregnant patients are
more susceptible to severe disease in influenza virus infection. All
six patients in a recent paper on pregnancy and swine-origin
H1N1/09 infection were reported to have primary viral
pneumonia and ARDS was documented in one of the six deaths
[31]. There is evidence that maternal immune responses are
diminished during pregnancy. Maternal lymphocytes obtained
during the second and third trimester show diminished prolifer-
ative responses to soluble antigens and allogeneic lymphocytes
[32–33] and cell-mediated cytotoxicity, the ability of CD8 T
lymphocytes to kill allogeneic or viral-infected cells, was also
reduced during pregnancy [34]. Abnormalities in NK cells have
received much less attention as a potential cause for immune
insufficiency during pregnancy; indeed NK cells are thought to be
crucial to the success of pregnancy [35,36]. Of the two major NK
cell subsets in human - the CD56
dim (cytotoxic) and the CD56
bright
(immuneregulatory) populations, CD56
bright NK cells are in-
creased in pregnancy. This subset is thought to provide benefit by
secreting cytokines, chemokines and angiogenic factors to control
trophoblastic invasion of the uterus [35].
The lack of circulating T cells to the conserved Matrix viral
protein is not entirely surprising in Patient 1 as it is possible that
these cells have homed to the lungs during the acute period. In
addition, virus-specific T cells are known to fluctuate during
infection [6]. However, we expected some of the remaining
activated CD8 effector T cells in Patient 3 (where sampling
occurred after the acute illness) to be Matrix-specific T cells since
this epitope is identical to the H1N1/09 influenza virus, and
particularly as the virus-infected, non-ventilated patient (P4)
showed an expansion of these T cells during the acute period. It
is also clear but not surprising that some individuals (H5 in
Figure 3d) maintain a more sizeable population of antigen-specific
T cells than others.
It is noteworthy that the CD4:CD8 T cell ratios were slightly
increased in the peripheral blood of the severely ill, ventilated
H1N1/09 patients (H1N1/09, ITU in Figure 3a) and even more
markedly in the infected non-ITU patients. There is continual
debate about the relative contribution of T cells to protection and
pathology in influenza virus infection. This finding raises the
hypothesis that the ‘cytokine storm’ observed in the serum of some
patients could be secondary to circulating CD4 T cells, while CD8
T cells are protective.
In summary, these three sequential severe cases serve as detailed
examples of severely ill patients from the new pandemic influenza
virus, and from which hypotheses might be generated. From the
immunological aspect, the reduction in NK cells raises the
interesting possibility of genetic polymorphisms affecting the NK
frequency or function; and the relative greater importance of NK
cells to T cells in the control of viral load and dissemination during
a first encounter with a new virus.
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